Axe Compute Inc. is a technology company specializing in high-performance AI infrastructure and compute services. Formerly known as Predictive Oncology, it has rebranded to focus on commercializing Aethir's decentralized GPU network, providing AI companies with reliable, enterprise-grade computing power backed by the Aethir Strategic Compute Reserve. This reserve supports critical needs such as GPU reservations, dedicated clusters, bare-metal performance, multi-regional deployments, and service level agreement (SLA) contracts. Axe Compute serves as the enterprise front-end for delivery and contracts, ensuring compliance with U.S. listed company governance while leveraging Aethir's underlying infrastructure of over 435,000 GPU containers worldwide, featuring high-end NVIDIA H100 and H200 hardware. The company continues its AI-driven drug discovery operations alongside expanding into AI infrastructure to address global compute shortages caused by long procurement timelines and cloud constraints. Founded in 2002 and operating in the healthcare equipment sector, Axe Compute bridges decentralized innovation with enterprise reliability, enabling innovators and businesses to access scalable, instant bare-metal GPUs.
Website91 43rd Street
Pittsburgh, PA, 15201
United States
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer ManagementPITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / (NASDAQ:MEDS) ("DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics Corporation ("Helomics") from Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company
Axe Compute (AGPU) sold its AI cancer diagnostics laboratory business called Helomics to DataMEDS AI
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy...
Investors talking about POAI also mention
What share of all stock conversation is about POAI?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% +0 | 0% 0 |
Of the messages about POAI that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% | 100% 0 | 70.43% -14.79 | ||
| Bearish | 0% | 0% | 0% 0 | 29.57% +14.79 |
Of the messages about POAI that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | — | — | 0% | ||
| Announcements | — | — | — | 77.57% | ||
| Controversies | — | — | — | 0% | ||
| Earnings | — | — | — | 0% | ||
| Macro | — | — | — | 0% | ||
| Technical Analysis | — | — | — | 22.43% |
Of the messages about POAI, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 100% | 100% | 31.8% | ||
| Newcomers | 0% | 0% | 0% | 68.2% |